Digital decision aid for HIV prevention after sexual assault
Pilot Testing of a Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault
This study is testing a new digital tool to help sexual assault survivors and their healthcare providers make better decisions about HIV prevention treatment after an assault.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Arkansas Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT06139354 on ClinicalTrials.gov |
What this trial studies
This trial aims to pilot a digital, interactive decision aid designed to assist patients and providers in making informed choices about HIV post-exposure prophylaxis (PEP) following sexual assault. The decision aid includes five sections that cover clinical factors, multimedia risk information, educational messaging about PEP, patient priority comparisons, and tailored feedback for shared decision-making. Given the urgency of initiating PEP within 72 hours of exposure, this tool seeks to enhance communication and clarity between patients and healthcare providers. The study addresses the inconsistency in offering PEP to sexual assault survivors, aiming to improve patient outcomes through better-informed decisions.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older who are seeking care within 72 hours of a sexual assault and can provide informed consent in English.
Not a fit: Patients who are under 18 years old, seeking care more than 72 hours after the assault, or those with minimal/low exposure risk will not benefit from this study.
Why it matters
Potential benefit: If successful, this decision aid could significantly improve the uptake and understanding of HIV PEP among sexual assault survivors, leading to better health outcomes.
How similar studies have performed: While the approach of using digital decision aids is gaining traction, this specific application for HIV PEP following sexual assault is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * seeking care from DCFNE following sexual assault * able to provide consent and participate in the study in English * meets CDC criteria for HIV PEP \[a) seeking care within 72 hours of potential exposure, b) potential exposure\] Exclusion Criteria: * \<18 years old * Does not meet CDC criteria for HIV PEP \[seeking care \>72 hours after assault, assault with minimal/low exposure risk\] * unable to complete study requirements in English
Where this trial is running
Washington D.C., District of Columbia
- District of Columbia Forensic Nurse Examiners — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Principal investigator: Jocelyn Anderson — Uams
- Study coordinator: Melissa Yu
- Email: jcandresearch@uams.edu
- Phone: (916) 360-0149
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.